Expression of survivin in adenoid cystic carcinoma of the lacrimal gland and the effect of intervention with arsenic trioxide in vitro
- PMID: 26170957
- PMCID: PMC4487053
- DOI: 10.3892/etm.2015.2466
Expression of survivin in adenoid cystic carcinoma of the lacrimal gland and the effect of intervention with arsenic trioxide in vitro
Abstract
The aim of the present study was to investigate the role of survivin in adenoid cystic carcinoma of the lacrimal gland (LGACC) and the effect of arsenic trioxide (As2O3) intervention in vitro. In total, 13 patients with LGACC were recruited from Renmin Hospital of Wuhan University between 2007 and 2012. The patients were divided into different groups, namely tumor-node-metastasis (TNM)1-2 and TNM3-4, according to the TNM classification. A total of eight samples were included in the TNM1-2 group, while five samples were included in the TNM3-4 group. In addition, six patients that suffered from other diseases (no tumor), but underwent eye surgery, were selected as the controls. The mRNA and protein expression levels of survivin were analyzed. In addition, primary adenoid cystic carcinoma (ACC) cells were cultured and the expression of survivin was silenced using short interfering RNA (siRNA), after which the cell proliferation was determined. Furthermore, the primary cultured ACC cells were treated with different doses of As2O3 to observe the effect on the apoptosis rate. The mRNA and protein expression levels of survivin in the LGACC groups were higher when compared with the controls (P<0.01). In addition, the expression levels were higher in the TNM3-4 group when compared with the TNM1-2 group (P<0.01). After silencing survivin expression using siRNA, the rate of ACC cell proliferation was shown to decrease at days 2, 3, 4 and 5 following culture, particularly in the TNM3-4 group at days 2 and 3 (P<0.05), day 4 (P<0.01 vs. TNM1-2 + siRNA); and days 3 and 5 (P<0.05), and day 2 (P<0.01 vs. TNM3-4 + siRNA). The mRNA expression levels of survivin in the TNM1-2 and TNM3-4 groups were significantly decreased following treatment with the various doses of As2O3 (2, 4 and 6 µΜ) for 48 h, and the apoptosis rate of the ACC cells was markedly increased (TNM1-2 and 3-4: As2O3 6 µM vs. As2O3 2 µM, As2O3 6 µM vs. As2O3 4 Μm, P<0.01; TNF3-4, As2O3 4 µM VS. As2O3 2 µM, P<0.01; TNM1-2, As2O3 4 µM vs. As2O3 2 µM, P<0.05). Therefore, survivin was demonstrated to be highly expressed in ACC cells of the lacrimal gland, and inhibition of survivin gene expression was found to suppress the proliferation of the ACC cells. Furthermore, As2O3 treatment was demonstrated to inhibit the mRNA expression of survivin in the ACC cells, while significantly increasing the apoptosis rate.
Keywords: adenoid cystic carcinoma; arsenic trioxide; lacrimal gland; survivin.
Figures
Similar articles
-
[Role of Survivin gene on the apoptosis of adenoid cystic carcinoma-2 cells induced by arsenic trioxide].Hua Xi Kou Qiang Yi Xue Za Zhi. 2010 Jun;28(3):246-9. Hua Xi Kou Qiang Yi Xue Za Zhi. 2010. PMID: 20635649 Chinese.
-
Influence of Ginkgo biloba extract on the proliferation, apoptosis of ACC-2 cell and Survivin gene expression in adenoid cystic carcinoma of lacrimal gland.Asian Pac J Trop Med. 2012 Nov;5(11):897-900. doi: 10.1016/S1995-7645(12)60167-9. Asian Pac J Trop Med. 2012. PMID: 23146805
-
[Influence of Ginkgo biloba extract on proliferation of ACC-2 cell, Survivin and TIP30 gene expression in adenoid cystic carcinoma of lacrimal gland].Zhongguo Zhong Yao Za Zhi. 2014 Dec;39(24):4860-4. Zhongguo Zhong Yao Za Zhi. 2014. PMID: 25898592 Chinese.
-
Arsenic trioxide inhibits proliferation in K562 cells by changing cell cycle and survivin expression.J Huazhong Univ Sci Technolog Med Sci. 2004;24(4):342-4, 353. doi: 10.1007/BF02861863. J Huazhong Univ Sci Technolog Med Sci. 2004. PMID: 15587394
-
Adenoid cystic carcinoma of the lacrimal gland metastatic to the kidney: case report and review of the literature.Scott Med J. 2014 May;59(2):e14-7. doi: 10.1177/0036933014530836. Epub 2014 Apr 1. Scott Med J. 2014. PMID: 24692233 Review.
Cited by
-
Lacrimal Gland Adenoid Cystic Carcinoma with High Grade Transformation: A Case Report and Current Concepts in Multi Modality Management.Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2599-2606. doi: 10.1007/s12070-020-02277-y. Epub 2020 Nov 25. Indian J Otolaryngol Head Neck Surg. 2022. PMID: 36452811 Free PMC article.
-
Pseudonormal Morphology of Salivary Gland Adenoid Cystic Carcinoma Cells Subverts the Antitumor Reactivity of Immune Cells: A Tumour-Cell-Based Initiation of Immune Evasion.Cancer Rep (Hoboken). 2024 Sep;7(9):e70019. doi: 10.1002/cnr2.70019. Cancer Rep (Hoboken). 2024. PMID: 39324702 Free PMC article.
-
Adenoid Cystic Carcinoma of the Lacrimal Gland.J Curr Ophthalmol. 2024 Oct 16;36(1):1-8. doi: 10.4103/joco.joco_231_23. eCollection 2024 Jan-Mar. J Curr Ophthalmol. 2024. PMID: 39553321 Free PMC article. Review.
-
MicroRNA-140-5p inhibits salivary adenoid cystic carcinoma progression and metastasis via targeting survivin.Cancer Cell Int. 2019 Nov 16;19:301. doi: 10.1186/s12935-019-1018-4. eCollection 2019. Cancer Cell Int. 2019. PMID: 31762692 Free PMC article.
References
-
- Zhou Q, Chang H, Han YD, Gao Y, Liu HG. High-grade transformation in adenoid cystic carcinoma: A clinicopathologic study. Zhonghua Bing Li Xue Za Zhi. 2013;42:106–110. (In Chinese) - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous